Advances in Clinical and Experimental Medicine

Zadzwoń Wskazówki dojazdu Strona internetowa Kontakt: praktyka

Advances in Clinical and Experimental Medicine IF 2.5, 5-Year IF 2.3, JCI (2025) 0.40, Scopus CiteScore 4.2, H-index 49 (SJR)
Initial editorial assessment and first decision within 24 h

🤝Meet the author of our latest editorial🤝Prof. Piotr Rzymski✔️ READ THE EDITORIALHealth misinformation and disinformatio...
29/10/2026

🤝Meet the author of our latest editorial🤝

Prof. Piotr Rzymski

✔️ READ THE EDITORIAL

Health misinformation and disinformation: Old narratives, new technologies

https://advances.umw.edu.pl/en/ahead-of-print/231630/

✔️SHORT BIO

Professor of Medical and Health Sciences at Poznan University of Medical Sciences in Poland, environmental and medical biologist, lecturer, science communicator. Co-author of several hundred peer-reviewed publications. Since 2020, included in the world's top 2% most-cited scientists ranking compiled by Stanford University and Elsevier. He serves as a member of the Infectious Diseases Advisory Group at the Polish Ministry of Health and as an expert for the European Research Executive Agency (REA). A former scholarship recipient of the Foundation for Polish Science and the Polish Ministry of Science and Higher Education. His achievements have been recognized with several prestigious awards, including the title of Healthcare Leader of the Year 2021 in Poland and the Grand Prize in the Polish Science Popularizer Award.

✔️MINI-INTERVIEW

In which thematic field is medical disinformation or misinformation most dangerous for patients?

Health-related disinformation is particularly dangerous when it discourages patients from seeking or receiving evidence-based medical interventions, whether preventive measures such as vaccination or treatments for specific diseases. This is when disinformation becomes a genuine threat to health and even life. There are also numerous examples of disinformation promoting untested therapies or methods that have already been demonstrated to be ineffective and/or harmful. Last but not least, from a broader perspective, health-related disinformation erodes public trust in healthcare institutions and medical professionals. This can have profound consequences for individual and public health, not to mention that it can be a tool for destabilizing national security.

What measures can a layperson take to avoid unintentionally spreading medical disinformation or misinformation?

One important step is to reduce our exposure to social media platforms, which have become major channels for spreading misinformation and disinformation and are increasingly flooded with AI-generated falsehoods and entirely fabricated content. It is particularly concerning that, for some people, short videos and social media posts have become not only their primary source of information about the world, including health-related issues, but increasingly their only source.

At the same time, we should refrain from sharing misleading or unverified content with others, even as a joke. It is also important to recognize that misinformation and disinformation often rely on emotional, provocative, and polarizing messages, whereas evidence-based communication tends to be more balanced and nuanced. Such characteristics should therefore prompt us to approach content with particular caution.

Last but not least, before passing information on to others, we should take a moment to verify its accuracy. This is easier than ever: we can consult reliable, independent sources, check the original evidence, or seek advice from qualified healthcare professionals. A simple rule worth following is: when in doubt, don't share.

What factors contribute to the dissemination of medical disinformation or misinformation by medical professionals?

Healthcare professionals are exposed to misinformation and disinformation just like everyone else. In today's information environment, this is virtually unavoidable. Unfortunately, some fall into the same traps as the general public. We should remember that having a medical degree does not automatically make someone immune to cognitive biases, emotional manipulation, or misleading narratives. Moreover, expertise in one medical field does not necessarily translate into expertise in another, particularly when it comes to critically evaluating scientific evidence.

Another important factor is the rapidly evolving nature of medical knowledge. Keeping up with the growing body of scientific literature is challenging, especially for healthcare professionals facing heavy workloads and limited time. As a result, some may rely on simplified messages, social media content, or information from sources that appear credible but are not necessarily trustworthy.

We should also acknowledge that, in some cases, spreading medical disinformation is not simply a matter of being misled. It may be driven by personal beliefs, ideological commitments, financial interests, or the pursuit of publicity and recognition, particularly on social media.

What makes this problem especially concerning is that healthcare professionals enjoy a high degree of public trust. Their professional titles and credentials lend credibility to their statements, even when those statements fall outside their area of expertise or contradict established scientific evidence. As a result, false information spread by a healthcare professional may be considerably more persuasive, and potentially more harmful, than the same claims made by someone without medical training.

🚀Recently published🚀It takes a society: A biopsychosocial approach to women’s brain health➡️Women face a disproportionat...
29/10/2026

🚀Recently published🚀

It takes a society: A biopsychosocial approach to women’s brain health

➡️Women face a disproportionately higher risk of poor brain health due to interacting biological, psychological, and social determinants, highlighting the need for a biopsychosocial approach.
➡️Addressing women’s brain health requires increased research investment, public health prioritization, and policies that consider both biological s*x differences and psychosocial factors.
➡️A comprehensive biopsychosocial framework can improve prevention, understanding, and long-term outcomes for women’s brain health across the lifespan.

🔗READ THE ARTICLE: https://advances.umw.edu.pl/en/ahead-of-print/225365/


🚀Recently published🚀Cross-cultural adaptation and assessment of psychometric properties of the Polish version of the Hai...
28/10/2026

🚀Recently published🚀

Cross-cultural adaptation and assessment of psychometric properties of the Polish version of the Hairdex Life Quality Questionnaire (Hairdex-PL)

➡️Hairdex-PL provides a disease-specific tool for assessing HRQoL in patients with hair and scalp disorders.
➡️Hairdex-PL demonstrated high internal consistency, with Cronbach’s α = 0.960 and McDonald’s ω = 0.963.
➡️Exploratory factor analysis identified a single-factor structure, differing from the original 5-factor Hairdex model.
➡️Hair loss and scalp disorders most strongly affected self-confidence and emotions, highlighting their psychosocial impact.

🔗READ THE ARTICLE: https://advances.umw.edu.pl/en/ahead-of-print/235992/




Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu
Dr hab. Michał Czapla

🤝Meet the author of our latest editorial🤝Dr. Andrea Fonseca de Paiva✔️ READ THE EDITORIALIt takes a society: A biopsycho...
27/10/2026

🤝Meet the author of our latest editorial🤝

Dr. Andrea Fonseca de Paiva

✔️ READ THE EDITORIAL

It takes a society: A biopsychosocial approach to women’s brain health

https://advances.umw.edu.pl/en/article/2026/35/9/1499/

✔️SHORT BIO
https://ojs.umw.edu.pl/files/acem/Andreia_Fonseca_de_Paiva_Short_Scientific_CV.pdf

✔️MINI-INTERVIEW

Which factor related to women’s brain health is, in your opinion, the most underestimated and/or misunderstood in Europe?

I believe the most misunderstood area is still the role of hormones in women's brain health: how hormonal changes across our reproductive life cycle can shape brain health throughout the lifespan. Increasingly, though, as we argue in our article on a biopsychosocial framework, we also need to consider sleep and stress linked to modern life, along with the social factors we encounter over our lives, all of which are interrelated. I'm glad there is now more awareness and more research into s*x and gender differences in conditions such as Alzheimer's disease. We are also beginning to examine women's reproductive health and its effects, not only on work but also on cognitive function across the life course.

Why are women underrepresented in clinical trials?

I think this is a question for funding bodies and governments. I don't understand why women are still so underrepresented in clinical trials. Perhaps conditions linked to women's reproductive health, or to female s*x hormones, are seen as less interesting to study; it may be that women are harder to reach, because they carry more societal and caregiving expectations. There's also still a real lack of engagement with, and understanding of, harder-to-reach communities. We as researchers can and should be vocal about the need to study women and for structural reforms so that research answers questions that respond to the needs of diverse populations. We believe that a biopsychosocial model is an important part of that puzzle.

You highlight the links between caregiving, chronic stress, sleep disruption, and brain health, while also emphasizing that responsibility should not be placed solely on individual women. What concrete changes in healthcare, workplaces or public policy could have the greatest impact on women’s brain health across the life course?

Caregiving responsibilities shouldn't fall solely on women. There needs to be more emphasis on shared roles within the family. We should also prioritize better support for women, not only in the workplace across their reproductive life cycle, so that they can stay in the workforce, but also by including them in policy design and change on the issues that affect them. And again, we need more funding for research into women's health.

🚀Recently published🚀Changes in hip joint anatomical shape as a predictor of osteoarthritisHighlights• Cam-type femoroace...
27/10/2026

🚀Recently published🚀

Changes in hip joint anatomical shape as a predictor of osteoarthritis

Highlights

• Cam-type femoroacetabular impingement (FAI) markers, including higher alpha angles and lower head–neck offset ratios, were more common in patients with hip osteoarthritis (HOA) and were associated with HOA group status.
• The largest between-group differences in alpha angle were observed on Dunn 45° and frog-leg lateral (LL) radiographs, suggesting that these views may be particularly informative for assessing cam-type morphology.
• In multivariable analysis, a higher LL alpha angle, greater anteroposterior (AP) femoral neck diameter, and a Dunn head–neck offset ratio

🚀Recently published🚀Pancytopenia and isolated cytopenias as hematological complications of SLE: A narrative reviewHighli...
26/10/2026

🚀Recently published🚀

Pancytopenia and isolated cytopenias as hematological complications of SLE: A narrative review

Highlights

➡️Pancytopenia affects 10–40% of patients with systemic lupus erythematosus (SLE) and may indicate severe disease activity or secondary bone marrow pathology.
➡️The pathogenesis is multifactorial, involving autoimmune bone marrow suppression, drug toxicity, hypersplenism, myelofibrosis, and macrophage activation syndrome.
➡️Accurate diagnosis requires comprehensive hematologic evaluation, bone marrow examination, and exclusion of differential diagnoses such as aplastic anemia and paroxysmal nocturnal hemoglobinuria.
➡️Rituximab demonstrates high initial response rates in SLE-related cytopenias, however randomized controlled trials show frequent relapses and difficulties maintaining long-term remissions.

🔗READ THE ARTICLE: https://advances.umw.edu.pl/en/ahead-of-print/214585/




Medyczny im. Piastów Śląskich we Wrocławiu

📢Call for Submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on Closing the Implementat...
24/10/2026

📢Call for Submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on Closing the Implementation Gap in Cardiometabolic Prevention in Primary Care📢

Despite the availability of evidence-based guidelines, the implementation of cardiometabolic prevention strategies in routine clinical practice remains suboptimal. Persistent gaps between recommended standards of care and real-world management of cardiovascular and metabolic risk have been consistently reported, particularly in primary care and general internal medicine settings.
This Special Issue of Adv Clin Exp Med aims to explore the scope, determinants, and consequences of the implementation gap in cardiometabolic prevention, as well as evidence-based strategies to address it. We invite original research and high-quality reviews that examine how preventive recommendations are translated into everyday practice, and which factors influence successful or failed implementation.

🧠Topics of interest include, but are not limited to:

➡️Real-world adherence to cardiovascular and cardiometabolic prevention guidelines

➡️System-, organizational-, and physician-level determinants of preventive care

➡️Barriers and facilitators of risk factor control in primary care settings

➡️Application of implementation science frameworks in general and internal medicine

➡️Population-based studies, registry analyses, and real-world data on prevention outcomes

➡️Comparative analyses of implementation strategies across healthcare systems or regions

🧠We particularly welcome multidisciplinary contributions integrating clinical medicine, epidemiology, public health, and health services research. Both quantitative and qualitative approaches, including mixed-methods studies, are encouraged.

🧠Keywords
preventive cardiology; cardiometabolic risk factors; evidence-based guidelines; healthcare delivery; quality of care; health system performance

🔗MORE INFORMATION
https://advances.umw.edu.pl/en/closing-implementation-gap

Dr hab. Michał Czapla
Robert Stanisław Śmigiel



Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

🚀Recently published🚀Clinical characteristics and risk factors for carbapenem-resistant Pseudomonas aeruginosa infectionH...
23/10/2026

🚀Recently published🚀

Clinical characteristics and risk factors for carbapenem-resistant Pseudomonas aeruginosa infection

Highlights

➡️High ICU incidence: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) infections were most common among ICU patients and predominantly originated from lower respiratory tract specimens.
➡️Major risk factors identified: Use of aminoglycosides (adjusted odds ratio (aOR) = 6.209) and carbapenems (aOR = 6.914) were identified as independent risk factors for CRPA infection.
➡️Elevated antibiotic resistance: CRPA strains showed significantly higher resistance to aztreonam, ciprofloxacin, levofloxacin, and cephalosporins compared with carbapenem-sensitive strains.
➡️Invasive procedures increase risk: Use of invasive mechanical ventilation, urinary catheters, and ICU admission was significantly associated with CRPA infection.
➡️Clinical implication: Rational antibiotic stewardship and minimization of unnecessary invasive procedures are essential for controlling CRPA infections and improving patient outcomes.

🔗READ THE ARTICLE: https://advances.umw.edu.pl/en/ahead-of-print/213798/


🚀Recently published🚀Awareness and acceptance of respiratory syncytial virus (RSV) vaccination among pregnant women in Po...
22/10/2026

🚀Recently published🚀

Awareness and acceptance of respiratory syncytial virus (RSV) vaccination among pregnant women in Poland: Results of an internet-based survey

Highlights

➡️Pregnant women in Poland show limited awareness and acceptance of RSV vaccination.
➡️Medical professionals and physician guidance significantly increase RSV vaccine uptake.
➡️Prior vaccination against influenza or pertussis is associated with greater willingness to receive RSV vaccination.
➡️Targeted education and public health campaigns are essential to improve RSV vaccination coverage.

🔗READ THE ARTICLE: https://advances.umw.edu.pl/en/ahead-of-print/212578/




Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

Call for Submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on📢Neurodegenerative disord...
21/10/2026

Call for Submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on

📢Neurodegenerative disorders in aging: From molecular mechanisms and biomarkers to translational therapeutic innovation📢

🧠Age-related neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, dementia-related syndromes, and other progressive neurological conditions, represent a growing clinical and public health challenge. Their increasing prevalence, driven largely by population aging, is accompanied by substantial diagnostic, therapeutic, and socioeconomic burdens. Despite major progress in neuroscience, effective disease-modifying interventions remain limited, and many conditions are still diagnosed at relatively advanced stages, when neuronal damage is already substantial.

🧠A better understanding of the molecular and cellular mechanisms underlying neurodegeneration is essential for the identification of clinically relevant biomarkers, validated therapeutic targets and innovative treatment strategies. Recent advances in neurochemistry, molecular biology, omics technologies, experimental pharmacology and translational neuroscience have opened new perspectives for drug discovery and therapeutic development. These include small molecules, natural compounds, biologics, peptides, gene- and RNA-based approaches, drug repurposing strategies and advanced drug delivery systems designed to overcome biological barriers such as the blood–brain barrier.
This article collection aims to highlight recent progress in understanding the mechanisms underlying age-related neurodegenerative disorders and their relevance to diagnosis, treatment, and prevention. Particular emphasis will be placed on studies that connect molecular or mechanistic findings with clinical relevance. Contributions addressing clinically useful biomarkers, validated disease targets, therapeutic candidates supported by experimental or clinical evidence, and innovative delivery systems tested in disease-relevant models are especially encouraged.

🧠The collection welcomes original research articles, systematic reviews, meta-analyses, focused reviews, and short communications that provide a clear translational message. Priority will be given to manuscripts that demonstrate how mechanistic insights may contribute to improved diagnosis, therapeutic decision-making, drug development, prevention strategies or patient outcomes.
Submitted manuscripts should be original, not previously published and not under consideration elsewhere. All submissions must meet internationally accepted standards for scientific reporting and follow the author guidelines, peer review procedures and editorial requirements of Advances in Clinical and Experimental Medicine.

🧠Scope of the collection

Authors are encouraged to submit manuscripts related to, but not limited to, the following areas:

➡️Molecular and cellular mechanisms of aging and neurodegeneration
➡️Neurotransmitter alterations and neurochemical pathways in health and disease
➡️Neuroinflammation, oxidative stress, excitotoxicity and mitochondrial dysfunction in neurodegenerative disorders
➡️Epigenetic, transcriptional and molecular remodeling in aging brain disorders
➡️Biomarkers for early diagnosis, disease monitoring and therapeutic response
➡️Novel therapeutic targets and drug discovery approaches in neurodegenerative diseases
➡️Small molecules, natural compounds, peptides and biotechnology-based products with therapeutic potential
➡️Gene-, RNA- and biologic-based therapeutic strategies
➡️Drug repurposing supported by experimental, translational or clinical evidence
➡️Brain-targeted drug delivery systems, including nanocarriers, microparticles, microneedle-based approaches and blood–brain barrier-focused technologies
➡️Pharmacological and non-pharmacological interventions with mechanistic or biomarker-based rationale
➡️Nutritional and lifestyle-related interventions linked to measurable biological or clinical outcomes
➡️Translational models relevant to neurodegenerative disease mechanisms and therapeutic testing

🧠Keywords
Aging; neurodegenerative disorders; neurochemistry; molecular mechanisms; cellular pathology; neuroinflammation; excitotoxicity; oxidative stress; mitochondrial dysfunction; biomarkers; therapeutic targets; drug discovery; translational neuroscience; blood–brain barrier; drug delivery.

MORE INFORMATION
🔗https://advances.umw.edu.pl/en/neurodegenerative-disorders

Adres

Karola Marcinkowskiego 2-6
Wroclaw
50-368

Godziny otwarcia

Poniedziałek 08:00 - 16:00
Wtorek 08:00 - 16:00
Środa 08:00 - 16:00
Czwartek 08:00 - 16:00
Piątek 08:00 - 16:00

Telefon

+48607983232

Powiadomienia

Bądź na bieżąco: wyślemy Ci e-mail, gdy Advances in Clinical and Experimental Medicine opublikuje nowości i promocje. Twój adres e-mail nie zostanie wykorzystany do żadnego innego celu, a subskrypcję możesz anulować w dowolnym momencie.

Kontakt: Praktyka

Wyślij wiadomość do Advances in Clinical and Experimental Medicine:

Skróty

Udostępnij

Kliniki w pobliżu